Meinian Onehealth and Philips Elevate Strategic Collaboration to Drive Intelligent Healthcare Innovation

VCBeat (WeChat ID: vcbeat) has learned that at the recently concluded 2019 Two Sessions, adhering to prevention-first principles and strengthening the prevention and control of major diseases became a key component of the Government Work Report. To implement the spirit of the Two Sessions and enhance the professional influence of preventive medicine and technology, Meinian Onehealth, a leading brand in the health checkup industry, joined hands with Philips, a global leader in health technology, to jointly host the “Caring for Health, Beautiful as You” strategic cooperation launch event at Shanghai Health Intelligence Valley on March 21.

At the meeting, both parties announced they would deepen their strategic partnership by integrating Philips’ technological strengths in health technology with Meinian Onehealth’s advantages in technology and practical channels in China. They aim to enhance the technological level of health examination services in areas such as product development, big data, and artificial intelligence, accelerate the implementation of practical applications, deliver higher-quality medical and healthcare services to consumers, and jointly safeguard the quality of life for the Chinese population.

At the conference, a new collaborative achievement was officially launched—the AI Breast intelligent ultrasound system, a key component of Philips’ Ultrasound iPlatform—designed to safeguard breast health.

Mr. Yu Rong, Chairman of Meinian Onehealth, Delivers a Speech

Mr. Yu Rong, Chairman of Meinian Onehealth, stated: “Meinian Onehealth is not only a large-scale, quality-driven chain of professional health checkup service providers, but also a data-driven health and life sciences technology company. We have been committed to contributing to technological breakthroughs in the field of life and health, as well as to the development and innovation of preventive medicine.”

"Partnering with globally renowned life sciences company Philips, both sides share aligned visions in 'health technology' and 'smart healthcare,' and will jointly explore the frontiers of life and health technologies to further advance the development of preventive medicine in China."

Mr. Li Zhiyong, Secretary-General of the China Association of Medical Equipment, Delivered a Speech

The two parties will deepen their strategic cooperation in the fields of medical technology and services by leveraging their complementary strengths. Philips is committed to the entire “healthcare journey,” covering “healthy lifestyles,” “disease prevention,” “diagnosis,” “treatment,” and “home care.” By leveraging advanced technologies, extensive clinical experience, and deep consumer insights, Philips continuously introduces integrated innovative solutions.

Meinian Onehealth is a large-scale professional health checkup and medical services group, with 600 checkup centers across more than 200 cities in China, serving nearly 30 million customers in 2018. As a leading platform for professional health examinations and preventive medicine with extensive influence in China, Meinian Onehealth enjoys unique advantages in scale and system, management and quality control, data accumulation, and medical resources.

Following the further deepening of their strategic cooperation, both parties will strengthen collaboration in medical product research and development as well as health big data research and application. They will also initiate joint exploration in the field of medical artificial intelligence, making medical technologies and products more suitable for health checkup scenarios, thereby improving the accuracy of disease screening and providing consumers with higher-quality health services.

Mr. He Guowei, Member of the Philips Global Executive Committee and CEO of Greater China, Delivers Remarks

Mr. He Guowei, Member of the Philips Global Executive Committee and CEO of Greater China, stated, “Philips fully supports the ‘Healthy China 2030’ vision and is committed to closely integrating global innovation with local needs. Meinian Onehealth boasts a vast customer base, a massive health big data platform, and a standardized medical service network spanning across China—all of which constitute valuable data and platform resources for the development of artificial intelligence.”

“Philips designated AI as a core component of its corporate innovation strategy five years ago, committing to become an AI-driven ‘practitioner’ in healthcare innovation and an active ‘participant’ in the local ecosystem. Looking ahead, we sincerely hope to continue our partnership with Meinian Onehealth, starting from health check-ups and disease prevention, to collaboratively address consumers’ detailed needs and pain points. Through joint innovation, we aim to leverage health technology advancements to better benefit the health of every Chinese citizen.”

At this press conference, the first step in deepening their strategic cooperation was the joint release of a new achievement—the AI Breast intelligent ultrasound system for breast diseases, an important component of Philips’ Ultrasound iPlatform.

According to the 2018 report by the National Cancer Center, in 2014, more than 10,000 people were diagnosed with cancer daily on average across China, with four deaths from cancer occurring every minute. Breast cancer is among the most prevalent cancers in the country. Built on the Philips EPIQ 5 intelligent ultrasound diagnostic system, AI Breast combines legendary image quality with “people-centric” intelligent applications to provide powerful decision support for healthcare professionals through visualization.

Ms. Chen Xiaosui, Vice President of Philips Greater China and General Manager of the Ultrasound Business Unit, delivered a speech

EPIQ 5 utilizes PureWave transducers to ensure high-quality imaging in breast examinations. Furthermore, Philips has developed a new intelligent ultrasound system—the AI Breast Intelligent Navigation System—based on its IntelliSpace Ultrasound platform, tailored to the specific needs of breast disease screening. By incorporating built-in sensors with magnetic field sensing technology, the system achieves comprehensive coverage during breast examinations, thereby reducing rates of missed and misdiagnoses.

Meinian Onehealth plans to deploy 15 EPIQ 5 systems at its Meinian MegaCheck health screening centers, equipped with the new AI Breast intelligent ultrasound system, to provide high-quality ultrasound screening services for women in need. Meinian Onehealth and Philips will further optimize and upgrade the equipment based on user feedback to enhance the accuracy of screening results and safeguard breast health.

While launching the new ultrasound application platform, both parties will also collaborate on ultrasound talent development and technical support to facilitate the practical implementation of the technology and ensure the accuracy of disease screening. In terms of talent development, Meinian Onehealth’s sonographers will receive targeted training from Philips’ global technical experts, enabling accurate screening and ensuring high efficiency and quality in health examinations.

The two parties also formulated the "Feichang Care" technical support plan, conducting nationwide follow-up visits for installed equipment. Through a series of comprehensive measures, including equipment maintenance, technical guidance, and the establishment of equipment archives, they promote the long-term and effective use of medical devices at Meinian Onehealth’s physical examination centers across China.

Furthermore, the deepened cooperation between both parties will focus on the future, with plans to jointly explore the application of artificial intelligence in the field of ultrasound. The two parties intend to establish a joint laboratory to develop an “Intelligent Control System for Ultrasound Scanning.” By integrating artificial intelligence technologies, this system aims to help physicians improve diagnostic speed and accuracy, promote more balanced and standardized medical care across different institutions, and reduce rates of misdiagnosis and missed diagnoses. This initiative not only actively responds to national policies on preventive medicine but also holds profound significance for delivering high-quality medical services in the health examination industry.

Through this deepened strategic partnership, Meinian Onehealth and Philips are joining forces to shoulder the critical responsibility of health defense. Their collaboration spans from product launches to subsequent equipment introduction, comprehensive training, technical support, and joint research and development in artificial intelligence. Leveraging big data and AI, they aim to drive intelligent technological innovation in the field of health examinations.

Undoubtedly, Meinian Onehealth will continue to be driven by quality and data, creating infinite possibilities in life sciences and health services. With a core focus on quality and innovation, it will remain a steadfast practitioner of the “Healthy China” national strategy, safeguarding the quality of life for every Chinese citizen.